Old Web
English
Sign In
Acemap
>
authorDetail
>
Carlos A. Doti
Carlos A. Doti
Novartis
Clinical trial
Dosing
Mesylate
Lost to follow-up
Adverse effect
1
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adherence to Imatinib Mesylate Treatment: Two Years Follow up
2008
Blood
Carlos A. Doti
German R Stemmelin
Elena Beatriz Moiraghi
María Gabriela Flores
Juan Garcia
Hector Murro
Eduardo Bullorsky
Show All
Source
Cite
Save
Citations (4)
1